Freet amends paid-in capital increase plan, names Emedison as third-party subscriber

• Freet Inc. corrected its paid-in capital increase terms, switching the third-party allottee to Emedison.
• Deal size cut to 1,600,004 common shares at KRW 2,500 each, implying gross proceeds of KRW 4.00001 billion.
• Operating-fund allocation reduced to KRW 1.81301 billion; remaining KRW 2.187 billion earmarked for debt repayment.
• Subscription date moved to Oct. 2, 2026; payment date set for Oct. 12, 2026; listing scheduled for Oct. 26, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Freet Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002000315), on October 02, 2026, and is solely responsible for the information contained therein.